Cervarix Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Human papillomavirus (HPV) vaccine types 16 & 18 (recombinant, AS04 adjuvanted)

Indications/Uses

Prevention of incident & persistent infection, premalignant ano-genital lesions (cervical, vulvar, vag & anal) (including ASCUS, CIN, VIN, VaIN, AIS) & cervical, vulvar, vag & anal cancers (squamous-cell carcinoma & adenocarcinoma) caused by oncogenic human papillomavirus (HPV) for individuals ≥9 yr.

Click to view Cervarix detailed prescribing information

Dosage/Direction for Use

IM in the deltoid region ≥15 yr 3-dose (at 0, 1, 6 mth) of 0.5 mL, 9-14 yr 2-doses of 0.5 mL, given between 5 & 13 mth after the 1st dose.

Click to view Cervarix detailed prescribing information

Overdosage

View Cervarix overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity.

Click to view Cervarix detailed prescribing information

Special Precautions

Do not administer intravascularly or intradermally. Anaphylactic event & syncope may occur. Postpone vaccination in patients w/ acute severe febrile illness. Thrombocytopenia or any coagulation disorder. Not intended for the prevention of progression of HPV-related lesions or protection against all oncogenic HPV types. Not a substitute for regular cervical screening or against exposure to HPV & STD. Immunocompromised patients. Pregnancy & lactation.

Click to view Cervarix detailed prescribing information

Use In Pregnancy & Lactation

Click to view Cervarix detailed prescribing information

Adverse Reactions

Headache; myalgia; inj site reactions including pain, redness, swelling, fatigue. GI disorders including nausea, vomiting, diarrhea & abdominal pain; itching/pruritus, rash, urticaria; arthralgia; fever (≥38°C).

Click to view Cervarix detailed prescribing information

Drug Interactions

Immunosuppressants.

Click to view Cervarix detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Cervarix detailed prescribing information

Storage

View Cervarix storage conditions for details to ensure optimal shelf-life.

Description

View Cervarix description for details of the chemical structure and excipients (inactive components).

Action

View Cervarix mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Vaccines, Antisera & Immunologicals

ATC Classification

J07BM02 - papillomavirus (human types 16, 18) ; Belongs to the class of papillomavirus vaccines.

Regulatory Classification

Presentation/Packing

Form

Cervarix vaccine (inj)

Packing/Price

(pre-filled syringe + 2 sterile needles) 0.5 mL x 1's (P1,658/pre-filled syringe)

Cervarix

vaccine, human papillomavirus types 16 and 18 (recombinant)

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig